P6
General Information
DRACP ID DRACP01091
Peptide Name P6
Sequence KWKLFKKIGIGKFKLAKKF
Sequence Length 19
UniProt ID Not available
PubChem CID Not available
Origin Ceropin A-Magainin 2
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
NCI-H128 | Lung small cell carcinoma; Small cell lung cancer | Carcinoma | IC50=2 µM | MTT assay | 72 h | 1 |
NCI-H146 | Lung small cell carcinoma; Small cell lung cancer | Carcinoma | IC50=3.1 µM | MTT assay | 72 h | 1 |
NCI-H69 | Lung small cell carcinoma; Small cell lung cancer | Carcinoma | IC50=1.7 µM | MTT assay | 72 h | 1 |
Hemolytic Activity Human red blood cells: hemolysis 0.2%(50 μg/mL); hemolysis 1.2%(100 μg/mL)
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C117H190N28O20
Absent amino acids CDEHMNPQRSTVY
Common amino acids K
Mass 263022
Pl 11.65
Basic residues 8
Acidic residues 0
Hydrophobic residues 9
Net charge 8
Boman Index -976
Hydrophobicity -32.11
Aliphatic Index 87.37
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 305.56
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 9352466
Title Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 19 and cecropin A-melittin hybrid peptides
Doi 10.1111/j.1399-3011.1997.tb01469.x
Year 1997
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available